Exithera raising $9M, develops pill as next-gen anti-stroke medication
Exithera Pharmaceuticals, a player in the anti-thrombosis and stroke prevention drug space, appears to be in the midst of a $9 million Series B round, according to regulatory filings. It has raised $3 million thus far, the filings said. Last we heard, the Westborough, Massachusetts company raised $2 million of a $4 million Series A […]